- Trials with a EudraCT protocol (147)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (5)
147 result(s) found for: Adenoma.
Displaying page 1 of 8.
EudraCT Number: 2006-007036-95 | Sponsor Protocol Number: CSOM230BDE01 | Start Date*: 2008-07-02 | |||||||||||
Sponsor Name:Universitätsklinikum Essen - Zentrum für Innere Medizin - Klinik für Endokrinologie | |||||||||||||
Full Title: Monocenter, double blinded, exploratory, randomized, study investigating the influence of Pasireotide on the hormonal activity of Prolactinomas - proof of concept study | |||||||||||||
Medical condition: Prolactinoma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-001084-27 | Sponsor Protocol Number: APAC | Start Date*: 2006-06-16 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERA OSPEDALI GALLIERA | |||||||||||||
Full Title: Phase I/II study of prevention of Colorectal Cancer CRC with Allopurinol in High-Risk Subjects | |||||||||||||
Medical condition: CHEMOPREVENTION OF COLORECTAL CANCER | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-004885-32 | Sponsor Protocol Number: 2013-004885-32 | Start Date*: 2015-03-03 |
Sponsor Name:Ospedale Valduce | ||
Full Title: The impact of split dosing preparation on adenoma detection rate: a randomized, investigator-blind, controlled trial | ||
Medical condition: Split dose bowel cleansing for colonoscopy | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: IT (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2006-002877-30 | Sponsor Protocol Number: CSOM230B2212 | Start Date*: 2006-12-22 | |||||||||||
Sponsor Name:NOVARTIS FARMA | |||||||||||||
Full Title: An open label, multicenter, pilot phase II study of SOM230 s.c. in patients with duodeno-pancreatic (neuro) endocrine tumors and different pituitary diseases (Nelsonメs syndrome, non-functioning ad... | |||||||||||||
Medical condition: duodeno-pancreatic (neuro) endocrine tumors and different pituitary diseases (Nelsonメs syndrome, non-functioning adenoma, TSH-adenoma,Gonadotroph adenoma, and PRL-adenoma) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-001815-29 | Sponsor Protocol Number: MDL_2011_36557 | Start Date*: 2011-11-11 | |||||||||||
Sponsor Name:UMC Utrecht | |||||||||||||
Full Title: Chemopreventive effects of mesalazine in patients at high risk of recurrent (nonfamilial) colorectal adenomas | |||||||||||||
Medical condition: sporadic colorectal adenomas | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-001351-40 | Sponsor Protocol Number: MES-CT01 | Start Date*: 2012-05-02 | ||||||||||||||||
Sponsor Name:SOFAR SPA | ||||||||||||||||||
Full Title: ND | ||||||||||||||||||
Medical condition: NA | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: IT (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2005-004413-15 | Sponsor Protocol Number: CSOM230B2209 | Start Date*: 2006-06-07 | |||||||||||
Sponsor Name:Cedars Sinai Medical Center | |||||||||||||
Full Title: Effectiveness of SOM230 In Treating Non-Functioning Pituitary Adenomas | |||||||||||||
Medical condition: non-functioning pitiutary adenomes | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-001711-38 | Sponsor Protocol Number: PC CO 201/08 | Start Date*: 2008-12-16 |
Sponsor Name:Photocure ASA | ||
Full Title: An open dose-finding study of oral applied hexaminolevulinate (HAL) imaging in patients with suspicion or high risk of dysplasia or neoplasia in the colon | ||
Medical condition: Patients with suspicion or high risk of neoplasia in the colon | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2009-012115-18 | Sponsor Protocol Number: IMP13617 | Start Date*: 2010-03-22 | |||||||||||||||||||||||||||||||||||||||||
Sponsor Name:UMC Utrecht | |||||||||||||||||||||||||||||||||||||||||||
Full Title: Primovist enhanced MRI for the detection and evaluation of focal liver lesions | |||||||||||||||||||||||||||||||||||||||||||
Medical condition: All benign and malignant focal liver lesions e.g. colorectal liver metastases, HCC, haemangioma, adenoma, cysts, FNH. | |||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||||||||||||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||||||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-010918-30 | Sponsor Protocol Number: 2377 | Start Date*: 2009-08-11 | ||||||||||||||||||||||||||||||||||||||||||||||
Sponsor Name:Amar Agha, Beaumont Hospital | ||||||||||||||||||||||||||||||||||||||||||||||||
Full Title: Effect of growth hormone replacement on cortisol-to-cortisone interconversion in hypopituitary patients with growth hormone deficiency and the influence of different aetiologies of hypopituitarism. | ||||||||||||||||||||||||||||||||||||||||||||||||
Medical condition: 20 patients with hypopituitarism including growth hormone deficiency will be evaluated both on growth hormone replacement and when they have been off it for a 2 month period. They will have been pr... | ||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||||||||||||||||||||||||||||||||
Trial protocol: IE (Ongoing) | ||||||||||||||||||||||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2004-000693-31 | Sponsor Protocol Number: COLO CP-01 | Start Date*: 2005-06-17 |
Sponsor Name:Colotech A/S | ||
Full Title: An international, multi centre, randomised, parallel group, prospective, double blind, placebo controlled clinical trial evaluating the efficacy and safety of a combination treatment administered o... | ||
Medical condition: Patients who have had removal of polyp in colon or rectum within 3 months. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FI (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2012-003983-32 | Sponsor Protocol Number: CB-17-01/06 | Start Date*: 2013-10-02 |
Sponsor Name:Cosmo Technologies Ltd | ||
Full Title: The safety and efficacy of Methylene Blue MMX® modified release tablets administered to subjects undergoing screening or surveillance colonoscopy. | ||
Medical condition: Polyp and adenoma detection during colonoscopy | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: IT (Completed) BE (Completed) DE (Completed) NL (Ongoing) LT (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2011-005694-23 | Sponsor Protocol Number: CB-17-01/05 | Start Date*: 2011-12-20 | |||||||||||||||||||||
Sponsor Name:COSMO TECHNOLOGIES LTD | |||||||||||||||||||||||
Full Title: Polyp detection rate after single oral dose of methylene blue MMX(R) modified release tablets administered to subjects undergoing outpatients colonoscopy | |||||||||||||||||||||||
Medical condition: patients scheduled for the screening or surveillance colonoscopy and meeting the joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer and the Ameri... | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Newborns, Infants and toddlers, Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: IT (Completed) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-000131-51 | Sponsor Protocol Number: 1921 | Start Date*: 2019-03-07 | ||||||||||||||||
Sponsor Name:Zealand University Hospital | ||||||||||||||||||
Full Title: Preoperative endoscopic treatment with fosfomycin and metronidazole in patients with right-sided colon cancer and colon adenoma: a clinical proof-of-concept intervention study MEFO trial | ||||||||||||||||||
Medical condition: Colon cancer in track 1. Colon adenoma in track 2. | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DK (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2008-007348-32 | Sponsor Protocol Number: CSOM230D2203 | Start Date*: 2009-05-06 | |||||||||||
Sponsor Name:Novartis Pharma Services AG | |||||||||||||
Full Title: An open label, multicenter, single arm study of pasireotide LAR in patients with rare tumors of neuroendocrine origin | |||||||||||||
Medical condition: The following tumors are included: 1. NETs of the pancreas or duodenum: Insulinoma, Gastrinoma, VIPoma, glucagonoma, 2. Pituitary NETs: Thyrotropic-pituitary adenoma (TSH), Gonadotropic adenoma, Pr... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) DE (Completed) IT (Completed) ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-001234-22 | Sponsor Protocol Number: NL52821.018.15 | Start Date*: 2015-07-01 | |||||||||||
Sponsor Name:Academic Medical Center | |||||||||||||
Full Title: A randomized placebo-controlled study in patients with a Gallium-68 DOTATATE PET/CT positive, clinically non-functioning pituitary macroadenoma (NFMA) of the effect of Lanreotide autosolution on Tu... | |||||||||||||
Medical condition: Clinically non-functioning pituitary macroadenoma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-000051-10 | Sponsor Protocol Number: A091200 | Start Date*: 2008-05-19 |
Sponsor Name:Cambridge University Hospitals NHS Foundation Trust and University of Cambridge | ||
Full Title: 11C metomidate PET scanning for Conn's syndrome | ||
Medical condition: Primary hyperaldosteronism - Conn's syndrome and bilateral adrenal hyperplasia. Imaging of adrenal lesions using 11C-metomidate PET. Pre-suppression with dexamethasone and/or fludrocortisone to opt... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2015-000411-40 | Sponsor Protocol Number: Version1.0 | Start Date*: 2015-10-23 |
Sponsor Name:Department of Nuclear Medicine and Endocrinology, Paracelsus Medical University Salzburg | ||
Full Title: Comparison of the detection of parathyroid adenoms using Tc-99m MIBI scintigraphy and F-18 Choline PET/CT in patients with primary hyperparathyroidism | ||
Medical condition: Primary hyperparathyroidism due to parathyroid adenoma | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2019-002562-12 | Sponsor Protocol Number: ENDOS2019 | Start Date*: 2019-09-09 |
Sponsor Name:HOSPITAL GENERAL DE CATALUNYA | ||
Full Title: PRAGMATIC, COMPARATIVE AND RANDOMIZED CLINICAL TRIAL OF THE NEW SOLUTION OF 1 LITER POLYETHYLENE GLYCOL VERSUS SODIUM PICOSULFATE WITH MAGNESIUM CITRATE IN THE EFFECTIVENESS OF SCREENING AND SURVE... | ||
Medical condition: Screening and surveillance colonoscopy | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2007-005568-28 | Sponsor Protocol Number: 2319/2007 | Start Date*: 2007-10-11 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERA PISANA | |||||||||||||
Full Title: Safety study of rosiglitazone in patients with acromegaly and assessment of biochemical parameters of disease's activity. | |||||||||||||
Medical condition: Acromegaly due to GH-secreting hypophysial adenoma, persistent after surgical adenomectomy, external radiotherapy or medical therapy with analogous of somatostatin. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
